Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%

MT Newswires Live

03/03

Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.

SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.

The company's Kiwi shares rose 5% in recent Tuesday trade.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2616536454"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616536454\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616536454?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 05:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616536454","market":"sh","top_or_hot":-1,"title":"Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-03 05:50</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2616536454","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616536454","pubTimestamp":1772488209,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  signed a service agreement with Singapore General Hospital , enabling clinicians to order Cxbladder Triage, TriagePlus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use TriagePlus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7067":"生物科技","BK7120":"特殊消费者服务","BK7031":"贸易公司与经销商","BK8033":"生物科技","PEB.AU":"PACIFIC EDGE LTD","SGH.AU":"SGH Ltd","PEB.NZ":"Pacific Edge Limited Ordinary Shares"},"translate_title":"Pacific Edge与新加坡总医院合作提供膀胱癌检测；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGH.AU":1,"PEB.NZ":1.5,"PEB.AU":1},"content_text":"Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}